132 related articles for article (PubMed ID: 2025496)
1. 32P-postlabeling detection of thymine glycols: evaluation of adduct recoveries after enhancement with affinity chromatography, nuclease P1, nuclease S1, and polynucleotide kinase.
Reddy MV; Bleicher WT; Blackburn GR
Cancer Commun; 1991 Apr; 3(4):109-17. PubMed ID: 2025496
[TBL] [Abstract][Full Text] [Related]
2. DNA adduction by phenol, hydroquinone, or benzoquinone in vitro but not in vivo: nuclease P1-enhanced 32P-postlabeling of adducts as labeled nucleoside bisphosphates, dinucleotides and nucleoside monophosphates.
Reddy MV; Bleicher WT; Blackburn GR; Mackerer CR
Carcinogenesis; 1990 Aug; 11(8):1349-57. PubMed ID: 2387021
[TBL] [Abstract][Full Text] [Related]
3. Nuclease S1-mediated enhancement of the 32P-postlabeling assay for aromatic carcinogen-DNA adducts.
Reddy MV
Carcinogenesis; 1991 Sep; 12(9):1745-8. PubMed ID: 1893535
[TBL] [Abstract][Full Text] [Related]
4. 32P-postlabeling detection of radiation-induced DNA damage: identification and estimation of thymine glycols and phosphoglycolate termini.
Weinfeld M; Soderlind KJ
Biochemistry; 1991 Jan; 30(4):1091-7. PubMed ID: 1846559
[TBL] [Abstract][Full Text] [Related]
5. Nuclease P1-mediated enhancement of sensitivity of 32P-postlabeling test for structurally diverse DNA adducts.
Reddy MV; Randerath K
Carcinogenesis; 1986 Sep; 7(9):1543-51. PubMed ID: 3017601
[TBL] [Abstract][Full Text] [Related]
6. 32P-adduct assay: comparative recoveries of structurally diverse DNA adducts in the various enhancement procedures.
Gupta RC; Earley K
Carcinogenesis; 1988 Sep; 9(9):1687-93. PubMed ID: 3409474
[TBL] [Abstract][Full Text] [Related]
7. Application of HPLC in the 32P-postlabeling assay.
Gorelick NJ
Mutat Res; 1993 Jul; 288(1):5-18. PubMed ID: 7686266
[TBL] [Abstract][Full Text] [Related]
8. Assay for reactive oxygen species-induced DNA damage: measurement of the formamido and thymine glycol lesions.
Maccubbin AE; Patrzyc HB; Ersing N; Budzinski EE; Dawidzik JB; Wallace JC; Iijima H; Box HC
Biochim Biophys Acta; 1999 May; 1454(1):80-8. PubMed ID: 10354517
[TBL] [Abstract][Full Text] [Related]
9. Quantitation of the 32P-postlabeling reaction using cyclic N1,N2 and C8 modified deoxyguanosine 3'-monophosphates as substrates.
Hemminki K; Szyfter K; Kadlubar FF
Chem Biol Interact; 1991; 77(1):51-61. PubMed ID: 1845762
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, characterization, and 32P-postlabeling of N-(deoxyguanosin)-4-aminobiphenyl 3'-phosphate adducts.
Haack T; Boche G; Kliem C; Wiessler M; Albert D; Schmeiser HH
Chem Res Toxicol; 2004 Jun; 17(6):776-84. PubMed ID: 15206898
[TBL] [Abstract][Full Text] [Related]
11. 32P-postlabeling of acrolein-deoxyguanosine adducts in DNA after nuclease P1 digestion.
Maccubbin AE; Lee L; Struck RF; Gurtoo HL
Chem Biol Interact; 1992 Sep; 84(1):21-35. PubMed ID: 1394614
[TBL] [Abstract][Full Text] [Related]
12. Detection of deoxyadenosine-4-aminobiphenyl adduct in DNA of human uroepithelial cells treated with N-hydroxy-4-aminobiphenyl following nuclease P1 enrichment and 32P-postlabeling analysis.
Hatcher JF; Swaminathan S
Carcinogenesis; 1995 Feb; 16(2):295-301. PubMed ID: 7859361
[TBL] [Abstract][Full Text] [Related]
13. A new sensitive 32P-postlabeling assay based on the specific enzymatic conversion of bulky DNA lesions to radiolabeled dinucleotides and nucleoside 5'-monophosphates.
Randerath K; Randerath E; Danna TF; van Golen L; Putman KL
Carcinogenesis; 1989 Jul; 10(7):1231-9. PubMed ID: 2544310
[TBL] [Abstract][Full Text] [Related]
14. Detection by 32P-postlabeling of thymidine glycol in gamma-irradiated DNA.
Hegi ME; Sagelsdorff P; Lutz WK
Carcinogenesis; 1989 Jan; 10(1):43-7. PubMed ID: 2910530
[TBL] [Abstract][Full Text] [Related]
15. 32P-postlabeling assay for carcinogen-DNA adducts: nuclease P1-mediated enhancement of its sensitivity and applications.
Reddy MV; Randerath K
Environ Health Perspect; 1987 Dec; 76():41-7. PubMed ID: 2834194
[TBL] [Abstract][Full Text] [Related]
16. 32P-Postlabeling analysis of DNA adducts of styrene 7,8-oxide at the O6-position of guanine.
Otteneder M; Eder E; Lutz WK
Chem Res Toxicol; 1999 Jan; 12(1):93-9. PubMed ID: 9894023
[TBL] [Abstract][Full Text] [Related]
17. 32-P-HPLC analysis of DNA adducts formed in vitro and in vivo by 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine and 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline, utilizing an improved adduct enrichment procedure.
Wohlin P; Zeisig M; Gustafsson JA; Möller L
Chem Res Toxicol; 1996 Sep; 9(6):1050-6. PubMed ID: 8870995
[TBL] [Abstract][Full Text] [Related]
18. C18 thin-layer chromatographic enhancement of the 32P-postlabeling assay for aromatic or bulky carcinogen-DNA adducts: evaluation of adduct recoveries in comparison with nuclease P1 and butanol methods.
Reddy MV
J Chromatogr; 1993 May; 614(2):245-51. PubMed ID: 8314936
[TBL] [Abstract][Full Text] [Related]
19. 32P-Postlabeling of N-(deoxyguanosin-8-yl)arylamine adducts: a comparative study of labeling efficiencies.
Mourato LL; Beland FA; Marques MM
Chem Res Toxicol; 1999 Jul; 12(7):661-9. PubMed ID: 10409407
[TBL] [Abstract][Full Text] [Related]
20. Postlabeling detection of DNA adducts of antitumor alkylating agents.
Zhou GH; Teicher BA; Frei E
Cancer Chemother Pharmacol; 1996; 38(1):71-80. PubMed ID: 8603455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]